PTCT
#1295
PTC Therapeutics, Inc. - Common Stock
59.9 2 USD
-0.05%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.77%
Variación mensual
-9.91%
Variación en los últimos 6 meses
-18.09%
Cambio anual
-8.98%
Cierres anteriores
62.9 2
Open
62.6 4
Mínimo
59.8 5
Máximo
62.7 5
Financials
- Market Capitalization 5 B
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
9.76
Relación precio/flujo de caja
3.88
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1274 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 79.62 USD | -7.48% | +1.05% | -18.40% | +13.53% | 5.17 B USD | ||
| 1275 |  ERAS Erasca, Inc. - Common Stock | 14.78 USD | -4.40% | +4.60% | -7.80% | +508.23% | 5.17 B USD | ||
| 1309 |  SRRK Scholar Rock Holding Corporation - Common Stock | 40.52 USD | -3.39% | -4.16% | -19.60% | +34.98% | 4.93 B USD | ||
| 1314 |  TVTX Travere Therapeutics, Inc. - Common Stock | 51.80 USD | -0.42% | -6.52% | -20.70% | +80.05% | 4.88 B USD |